Veronica Sancho

Veronica Sancho

Auto-generated profile, based on publicly available information

Veronica Sancho

Diabetes and Metabolic Disease Section, Department of Clinical and Experimental Medicine, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 2 Via Paradisa, 56124, Pisa, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
VSVeronica Sancho
Veronica Sancho
AFAlessia Di Florio
Alessia Di Florio
TMTerry W. Moody
Terry W. Moody
RJRobert T Jensen
Robert T Jensen
The three mammalian bombesin (Bn) receptors (gastrin-releasing peptide [GRP] receptor, neuromedin B [NMB] receptor, BRS-3) are one of the classes of G protein-coupled receptors that are most frequently overexpress/ ectopically expressed by common, important malignancies. Because of the clinical success of somatostatin receptor- mediated imaging and cytotoxicity with neuroendocrine tumors, there is now increasing interest in pursuing a similar approach with Bn receptors. In the last few years then have been more than 200 studies in this area. In the present paper, the in vitro and in vivo results, as well as results of human studies from many of these studies are reviewed and the current state of Bn receptor-mediated imaging or cytotoxicity is discussed. Both Bn receptor-mediated imaging studies as well as Bn receptor-mediated tumoral cytotoxic studies using radioactive and non-radioactive Bn-based ligands are covered.

1 March 2005 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
IVIsabel Valverde
Isabel Valverde
JPJesús Puente
Jesús Puente
AMAntonio Martín-Duce
Antonio Martín-Duce
LMLuis Molina
Luis Molina
OLOscar Lozano
Oscar Lozano
MVMaría Luisa Villanueva-Peñacarrillo
María Luisa Villanueva-Peñacarrillo

1 March 2005 in Regulatory Peptides
Verified
Journal Article
Closed access
NGNieves González
Nieves González
AAAlicia Acitores
Alicia Acitores
VSVerónica Sancho
Verónica Sancho
IVIsabel Valverde
Isabel Valverde
MVMaría L. Villanueva-Peñacarrillo
María L. Villanueva-Peñacarrillo

1 December 2007 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
MBMarc J Berna
Marc J Berna
Jose A. TapiaJose A. Tapia
Jose A. Tapia
VSVeronica Sancho
Veronica Sancho
RJRobert T Jensen
Robert T Jensen

1 August 2005 in Journal of Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
VSVerónIca Sancho
VerónIca Sancho
MTMaría V Trigo
María V Trigo
NGNieves GonzálEz
Nieves GonzálEz
IVIsabel Valverde
Isabel Valverde
WMWilly J Malaisse
Willy J Malaisse
MVMaría L Villanueva-PeñaCarrillo
María L Villanueva-PeñaCarrillo
Several kinases have been implicated in the metabolic response of human and rat myocytes to glucagon-like peptide-1 (GLP-1), exendin-4 (Ex-4) and exendin-9 (Ex-9). We have investigated, in isolated rat adipocytes, the changes caused by GLP-1, Ex-4 and Ex-9 compared with those provoked by insulin or glucagon, upon the activity of phosphatidylinositol-3-kinase (PI3K), protein kinase B (PKB), p42/44 MAP kinases (MAPKs) and p70s6 kinase (p70s6k), and the participation of these kinases and protein kinase C (PKC) in their action upon 2-deoxy-d-glucose uptake, lipolysis and lipogenesis. The study was conducted in normal rats, and extended to a streptozotocin-induced type-2 diabetic model (STZ-rats). The participation of distinct kinases was estimated by using potential kinase inhibitors, including wortmannin, PD98059, rapamycin, H-7 and RO31–8220. In normal rat adipocytes, GLP-1 and both exendins share with insulin an increasing action upon the activity of all kinases studied (except PKB), PI3K, p44 and p42 MAPKs and possibly PKC, all being required for their stimulating effect upon glucose uptake. Ex-4 and Ex-9, like GLP-1 and insulin, have lipogenic action, while only Ex-4 shares with GLP-1 its lipolytic effect which is antagonized by Ex-9. MAP kinases and PKC seem to have an essential role in the GLP-1 and Ex-4 lipolytic action, as does PI3K in that of Ex-4. An increase in PI3K and MAPKs activity for the lipogenic effect of Ex-4, Ex-9 and GLP-1 are required, and in the case of Ex-4 and Ex-9, a stimulation of p70s6k activity is also needed. In cells from STZ-rats the magnitude of the above parameters was, in general, comparable to that in normal animals, with some exceptions: basal PI3K activity and lipogenesis were higher, GLP-1, Ex-4 and Ex-9 failed to modify basal lipogenesis but increased PKB activity, insulin failed to affect the activity of MAPKs and the insulin-induced glucose uptake was impaired. The impaired insulin effects upon some of the variables in the STZ-rat, distinct from those of GLP-1 and exendins, adds knowledge to the mechanism of the beneficial action of GLP-1 and Ex-4 in diabetic states.

1 July 2010 in European Journal of Pharmacology
Verified
Journal Article
Closed access
TMTerry W. Moody
Terry W. Moody
MBMarc J. Berna
Marc J. Berna
SMSamuel Mantey
Samuel Mantey
VSVeronica Sancho
Veronica Sancho
LRLisa Ridnour
Lisa Ridnour
RJRobert T. Jensen
Robert T. Jensen